Diametric Capital’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$282K	Sell	102,955 -66,051	-39%	-$209K	0.07%	343
2025 Q4	$625K	Sell	169,006 -67,139	-28%	-$217K	0.17%	170
2025 Q3	$626K	Sell	236,145 -442,679	-65%	-$856K	0.23%	108
2025 Q2	$668K	Buy	678,824 +248,648	+58%	+$249K	0.36%	82
2025 Q1	$619K	Buy	430,176 +76,166	+22%	+$140K	0.74%	32
2024 Q4	$779K	Sell	354,010 -312,829	-47%	-$730K	0.53%	54
2024 Q3	$1.1M	Sell	666,839 -77,003	-10%	-$155K	0.54%	39
2024 Q2	$1.65M	Buy	743,842 +667,058	+869%	+$1.57M	0.9%	18
2024 Q1	$206K	Sell	76,784 -11,386	-13%	-$27.7K	0.11%	259
2023 Q4	$264K	Buy	+88,170	New	+$114K	0.16%	174
2021 Q2	–	Sell	-8,902	Closed	-$250K	–	153
2021 Q1	$250K	Buy	+8,902	New	+$263K	0.19%	106